InvestorsHub Logo
Followers 864
Posts 27574
Boards Moderated 1
Alias Born 11/05/2010

Re: PoemStone post# 4896

Thursday, 09/20/2012 8:01:54 AM

Thursday, September 20, 2012 8:01:54 AM

Post# of 5074
SVNT. Savient Announces Multiple Abstracts Related to KRYSTEXXA® in the Treatment of Refractory Chronic Gout to be Presented at the 2012 ACR/ARHP Annual Meeting
http://finance.yahoo.com/news/savient-announces-multiple-abstracts-related-113000941.html

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.